TNF‐α is a highly proinflammatory cytokine, which is involved in the activation of NF‐κB pathway and its vicious cycle, thus blocking TNF‐α is a potential therapeutic strategy for hyperinflammation and CS in COVID‐19.147, 358, 359, 360. Here, NFKB1 is linked to COVID-19.